Skip to content
2000
Volume 21, Issue 30
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Based on the global burden of tuberculosis and resistant strains that have recently emerged, not responding to existing therapies, it has become urgent to search for new remedies against this global human plague that has been compounded by HIV co-infection. Thus, the search for new drugs against the disease-causing agent, Mycobacterium tuberculosis (MTB), is an ongoing effort. This review discusses the state-of-the-art in anti-tuberculosis pathogenesis and anti-TB drug research, identifying some of the challenges being faced by researchers in the field and sheds light on possible ways forward, particularly in low-income countries.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867321666140706144933
2014-10-01
2025-06-19
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867321666140706144933
Loading

  • Article Type:
    Research Article
Keyword(s): Drug discovery; drug resistance; in silico screening; tuberculosis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test